Malmo, Sweden

Arne Nilsson



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1992-1997

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arne Nilsson: Innovator in Pharmaceutical Chemistry

Introduction

Arne Nilsson is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and formulations. With a total of 3 patents, Nilsson has established himself as a key figure in the industry.

Latest Patents

Among his latest patents is a process for preparing delmopinol via intermediates known as isoxazolidines. This invention focuses on a new method for synthesizing delmopinol using specific intermediates characterized by the formula wherein R is 2-propylpentyl, which may contain one to three internal unsaturated bonds, or 2-substituted-2-propylpentyl with one or two internal unsaturated bonds, where the 2-substituent acts as a leaving group. This innovative approach showcases Nilsson's expertise in chemical processes.

Career Highlights

Throughout his career, Arne Nilsson has worked with prominent companies in the pharmaceutical sector, including Kabi Pharmacia Aktiebolag and Pharmacia AB. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in drug formulation and delivery.

Collaborations

Nilsson has collaborated with several professionals in his field, including Elisabeth Seifert and Sven Hernestam. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Arne Nilsson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…